Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01157Infliximab--
BADD_D01159Insulin (human)--
BADD_D01160Insulin aspart--
BADD_D01161Insulin degludec--
BADD_D01162Insulin detemir--
BADD_D01163Insulin glargine--
BADD_D01166Interferon alfa-2a--
BADD_D01167Interferon alfa-2b--
BADD_D01170Interferon beta-1b--
BADD_D01171Interferon gamma-1b--
BADD_D01178Iodixanol0.774648%
BADD_D01180Iohexol4.764547%
BADD_D01181Iopamidol0.492958%
BADD_D01182Iopromide2.288377%
BADD_D01183Iothalamate meglumine--
BADD_D01184Iothalamic acid--
BADD_D01186Ioversol2.071418%
BADD_D01187Ioxaglate meglumine--
BADD_D01188Ioxaglic acid--
BADD_D01189Ioxilan--
BADD_D01191Ipratropium--
BADD_D01192Ipratropium bromide--
BADD_D01193Ipratropium bromide monohydrate--
BADD_D01194Irbesartan0.001173%
BADD_D01195Irinotecan0.000280%
BADD_D01197Iron0.000907%
BADD_D01198Iron dextran--
BADD_D01199Iron sucrose--
BADD_D01201Isavuconazonium sulfate--
BADD_D01204Isoniazid--
The 22th Page    First    Pre   22 23 24 25 26    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target